These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 16728701)

  • 1. Dysregulated TCL1 requires the germinal center and genome instability for mature B-cell transformation.
    Shen RR; Ferguson DO; Renard M; Hoyer KK; Kim U; Hao X; Alt FW; Roeder RG; Morse HC; Teitell MA
    Blood; 2006 Sep; 108(6):1991-8. PubMed ID: 16728701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TORC2 regulates germinal center repression of the TCL1 oncoprotein to promote B cell development and inhibit transformation.
    Kuraishy AI; French SW; Sherman M; Herling M; Jones D; Wall R; Teitell MA
    Proc Natl Acad Sci U S A; 2007 Jun; 104(24):10175-80. PubMed ID: 17548807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global DNA methylation profiling reveals silencing of a secreted form of Epha7 in mouse and human germinal center B-cell lymphomas.
    Dawson DW; Hong JS; Shen RR; French SW; Troke JJ; Wu YZ; Chen SS; Gui D; Regelson M; Marahrens Y; Morse HC; Said J; Plass C; Teitell MA
    Oncogene; 2007 Jun; 26(29):4243-52. PubMed ID: 17260020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smc3 dosage regulates B cell transit through germinal centers and restricts their malignant transformation.
    Rivas MA; Meydan C; Chin CR; Challman MF; Kim D; Bhinder B; Kloetgen A; Viny AD; Teater MR; McNally DR; Doane AS; Béguelin W; Fernández MTC; Shen H; Wang X; Levine RL; Chen Z; Tsirigos A; Elemento O; Mason CE; Melnick AM
    Nat Immunol; 2021 Feb; 22(2):240-253. PubMed ID: 33432228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human B Lymphomas Reveal Their Secrets Through Genetic Mouse Models.
    Mossadegh-Keller N; Brisou G; Beyou A; Nadel B; Roulland S
    Front Immunol; 2021; 12():683597. PubMed ID: 34335584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TCL1 in B-cell tumors retains its normal b-cell pattern of regulation and is a marker of differentiation stage.
    Herling M; Patel KA; Hsi ED; Chang KC; Rassidakis GZ; Ford R; Jones D
    Am J Surg Pathol; 2007 Jul; 31(7):1123-9. PubMed ID: 17592280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AID-associated DNA repair pathways regulate malignant transformation in a murine model of BCL6-driven diffuse large B-cell lymphoma.
    Gu X; Booth CJ; Liu Z; Strout MP
    Blood; 2016 Jan; 127(1):102-12. PubMed ID: 26385350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mice deficient for CD137 ligand are predisposed to develop germinal center-derived B-cell lymphoma.
    Middendorp S; Xiao Y; Song JY; Peperzak V; Krijger PH; Jacobs H; Borst J
    Blood; 2009 Sep; 114(11):2280-9. PubMed ID: 19608748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of sprouty2 inhibits B-cell proliferation and is epigenetically silenced in mouse and human B-cell lymphomas.
    Frank MJ; Dawson DW; Bensinger SJ; Hong JS; Knosp WM; Xu L; Balatoni CE; Allen EL; Shen RR; Bar-Sagi D; Martin GR; Teitell MA
    Blood; 2009 Mar; 113(11):2478-87. PubMed ID: 19147787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determining the Origin of Human Germinal Center B Cell-Derived Malignancies.
    Seifert M; Küppers R
    Methods Mol Biol; 2017; 1623():253-279. PubMed ID: 28589362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the catalytic function of activation-induced cytidine deaminase promotes apoptosis of germinal center B cells in BXD2 mice.
    Hsu HC; Yang P; Wu Q; Wang JH; Job G; Guentert T; Li J; Stockard CR; Le TV; Chaplin DD; Grizzle WE; Mountz JD
    Arthritis Rheum; 2011 Jul; 63(7):2038-48. PubMed ID: 21305519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AID is required for germinal center-derived lymphomagenesis.
    Pasqualucci L; Bhagat G; Jankovic M; Compagno M; Smith P; Muramatsu M; Honjo T; Morse HC; Nussenzweig MC; Dalla-Favera R
    Nat Genet; 2008 Jan; 40(1):108-12. PubMed ID: 18066064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TCL1 oncogene expression in B cell subsets from lymphoid hyperplasia and distinct classes of B cell lymphoma.
    Said JW; Hoyer KK; French SW; Rosenfelt L; Garcia-Lloret M; Koh PJ; Cheng TC; Sulur GG; Pinkus GS; Kuehl WM; Rawlings DJ; Wall R; Teitell MA
    Lab Invest; 2001 Apr; 81(4):555-64. PubMed ID: 11304575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysregulated TCL1 promotes multiple classes of mature B cell lymphoma.
    Hoyer KK; French SW; Turner DE; Nguyen MT; Renard M; Malone CS; Knoetig S; Qi CF; Su TT; Cheroutre H; Wall R; Rawlings DJ; Morse HC; Teitell MA
    Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14392-7. PubMed ID: 12381789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fas and Fas ligand expression on germinal center type-diffuse large B-cell lymphoma is associated with the clinical outcome.
    Kojima Y; Tsurumi H; Goto N; Shimizu M; Kasahara S; Yamada T; Kanemura N; Hara T; Sawada M; Saio M; Yamada T; Takahashi T; Tomita E; Takami T; Moriwaki H
    Eur J Haematol; 2006 Jun; 76(6):465-72. PubMed ID: 16494623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Msh6 protects mature B cells from lymphoma by preserving genomic stability.
    Peled JU; Sellers RS; Iglesias-Ussel MD; Shin DM; Montagna C; Zhao C; Li Z; Edelmann W; Morse HC; Scharff MD
    Am J Pathol; 2010 Nov; 177(5):2597-608. PubMed ID: 20934970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The proto-oncogene MYC is required for selection in the germinal center and cyclic reentry.
    Dominguez-Sola D; Victora GD; Ying CY; Phan RT; Saito M; Nussenzweig MC; Dalla-Favera R
    Nat Immunol; 2012 Nov; 13(11):1083-91. PubMed ID: 23001145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Ig/BCL6 translocations with germinal center B lymphocytes in human lymphoid tissues: implications for malignant transformation.
    Yang X; Lee K; Said J; Gong X; Zhang K
    Blood; 2006 Sep; 108(6):2006-12. PubMed ID: 16728698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined deletion of Xrcc4 and Trp53 in mouse germinal center B cells leads to novel B cell lymphomas with clonal heterogeneity.
    Chen Z; Elos MT; Viboolsittiseri SS; Gowan K; Leach SM; Rice M; Eder MD; Jones K; Wang JH
    J Hematol Oncol; 2016 Jan; 9():2. PubMed ID: 26740101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutant EZH2 Induces a Pre-malignant Lymphoma Niche by Reprogramming the Immune Response.
    Béguelin W; Teater M; Meydan C; Hoehn KB; Phillip JM; Soshnev AA; Venturutti L; Rivas MA; Calvo-Fernández MT; Gutierrez J; Camarillo JM; Takata K; Tarte K; Kelleher NL; Steidl C; Mason CE; Elemento O; Allis CD; Kleinstein SH; Melnick AM
    Cancer Cell; 2020 May; 37(5):655-673.e11. PubMed ID: 32396861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.